Home
Project
Partners
Advisory board
Investigators
Institutes
LUMC
Inserm
UCL
Great Ormond Street
Ospedale San Raffaele
Hannover Medical School
University of Ulm
Wroclaw University
Newcastle University
IPOPI
Batavia Biosciences
Vall d’Hebron Hospital
Bambino Gesù
SCETIDE
Sheba Medical Center
LMU
GeneWerk
Partner area
Impact
Resources
Leaflet
Videos
Contact
News
RECOMB
Clinical trial for RAG1-SCID
Develop
Develop an autologous haematopoietic stem cell‒based gene therapy within a multinational, multicentre clinical trial for treating RAG1-SCID.
Treat
Treat the patients with the developed RAG1-SCID gene therapy eliminating complications and increasing survival.
Impact
Make gene therapy a realistic option for > 70% of all SCID patients in Europe with reduced healthcare costs.
News
Read more
September 26, 2022
TV programme about our first successfully treated patient
June 22, 2022
First patient in the Netherlands successfully treated with stem cell gene therapy
